1 石英,周育森,郭彦,等.应用梭状芽孢杆菌口服疫苗载体表达HIV p24蛋白的研究[J].科学技术与工程,2007,7(17):4265~4270,4276. 2 吴国豪.肠道屏障功能[J].肠外与肠内营养,2004,11(1):44~47. 3 李丽,谯仕彦,祝发明,等.蜜蜂抗菌肽Abaecin在枯草杆菌中的分泌表达[J].畜牧兽医学报,2009,40(11):1681~1685. 4 李丽.芽孢型益生菌黏膜疫苗平台的构建与生物学特性研究.广州:中山大学,2009. 5 李志会,岳盈盈,李鹏,等.EV71 VP1黏膜疫苗制备及其诱导黏膜免疫的实验研究[J].山东医药,2011,51(43):4~5. 6 陆扬,姚文,朱伟云.益生菌—新型免疫调节剂[J].微生物学报,2005,32(4):144~148. 7 周珍文,胡旭初,邓秋连,等.枯草杆菌芽孢抵抗胃肠道环境的耐性评估[J].热带医学杂志,2008,8(3):235~237. 8 梁晋琼,柴桂珍,石晋虎. 枯草芽孢杆菌活菌制剂对牛羊细菌性腹泻预防和治疗效果的研究[J].中国畜牧兽医,2007,34(8): 98~100. 9 傅晓燕,陈卫,张灏.耐热半乳糖苷酶基因在枯草芽孢杆菌中的克隆和表达[J].中国酿造,2004,8(137):438~441. 10 Barak I,Ricca E,Cutting M.From fundamental studies of sporulation to applied spore research[J].Mol Microbiol,2005,55:330~338. 11 Barnes A G,Cerovic V,Hobson P S,et al.Bacillus subtilis spores:A novel microparticle adjuvant which can instruct a balanced Th1 and Th2 immune response to specific antigen[J].Eur J Immunol,2007,37:1538~1547. 12 Brandtzaeg P,Fastad I N,Haraldsen G.Regional specialization in the mucosal immune system:Primed cells do dot always home along the same track[J].Immunol Today,1998,32(6):314~321 13 Chada V G,Sanstad E A,Wang R,et al.Morphogenesis of Baciilus spore surfaces[J].J Bacteriol,2003,185(21):6255~6261. 14 Diks A.The dynamic spore[J].Proc Nat Acad Sci,2003,100(6):3007~3009. 15 Duc L H,Hong H A,Athins H S,et al.Immunization against anthrax using Bacillus subtilis spores experessing the anthrax protective antigen[J].Vaccine,2007,25(2):346~355. 16 Duele H,Hong H A,Uyen N Q,et al.Intracellular fate and immunogenicity of B.subtilis spores[J].Vaccine,2004,22:1873~1885. 17 Hellen A,Sangun Lee,Kathryn K,et al.Sublingual immunization with an engineered Bacillus subtilis strain expressing tetanus toxin fragment C induces systemic and mucosal immune responses in piglets[J].Microbes and Infection,2012,14(5):447~456. 18 Hiroshi K,Yasushi K,Keiji E,et al.Secretion of biologically-active human interferon-β by Bacillus subtilis[J].Biotechnol Lett,2011,33:1847~1852. 19 Hoang H,Hong A,Clark C,et al.Recombinant Bacillus subtilis expressing the Clostridium perffingens alpha toxoid is a candidate orally delivered vaccine against necrotic enteritis[J].Infect Immun,2008,76:5257~5265. 20 Inoue Y,Miki C,Kusunoki M.Nutritional status and cytokine-related protein breakdown in elderly patients with gastrointestinal malignancies[J].Surg Oncol,2004,86(2):91~98. 21 Isolauri E,Salminen S,Ouwehanda C. Probiotics[J].Best Practice & Research Clinical Gastroenterology,2004,18(2):299~313. 22 Isticato R,Cangiano G,Tran T,et al.Surface display of recombinant proteins on Bacillus subtilis spores[J].Journal of Bacteriology,2001,183:6294~6301. 23 Manki S,Huynh A H,Jen-Min H,et al.Killed Bacillus subtilis spores as a mucosal adjuvant for an H5N1 vaccine[J].Vaccine,2012,30(22):3266~3277. 24 Mauriello F,Duc H,Isticato R,et al.Display of heterologous antigens on the Bacillus subtilis spore coat using CotC as a fusion partner[J].Vaccine,2004,22:1177~1187. 25 Medici M,Vinderola C G,Perdigon G.Gutmucosal immunomodulation by probiotic fresh cheese[J].International Dairy Journal,2004,14(7):611~618. 26 Moreno D E,Leblanc A,Chaves S,et al.Effect of long-term continuous consumption of fermented milk containing probiotic bacteria on mucosal immunity and the activity of peritoneal acrophags[J].Immunobilolgy,2008,213:97~108. 27 Vaerman J P.Contribution of serum IgA to intestinal lymph IgA,and vice versa,in minipigs[J].Veterinary Immunology andImmunopathology,1997,58:301~308. 28 Vinderola G,Matar C.Milk fermented by Lactobacillus helveticus R389 and its non-bacterial fraction confer enhanced protection against Salmonella enteritidis serovar Typhimurium infection in mice[J].Immunobiology,2007,212(2):107~118. 29 Zhou Z,Xia H,Hu X,et al.Oral administration of a Bacillus subtilis spore-based vaccine expressing Clonorchis sinensis tegumental protein 22.3 kDa confers protection against Clonorchis sinensis[J].Vaccine,2008,26:1817~1825. |